For patients diagnosed with a brain metastasis, or cancer that began elsewhere in the body and end up in the brain, advances in treatments, such as targeted immunotherapy, are living longer. View this American Brain Tumor Association's Educational Webinar, "Metastatic Brain Tumors 101" and learn more about managing symptoms and side effects of metastatic brain tumors.
This webinar will be presented by Dr. Minesh Mehta, MD, FASTRO, Deputy Director and Chief of Radiation Oncology at the Miami Cancer Institute.
-Video Contents-
0:00 Introduction
4:52 Epidemiology of metastatic brain tumors
5:59 How are metastatic brain tumors discovered?
15:52 The QUARTZ Trial
20:37 Prognostic Tools
20:52 Revised ds-GPA Description
23:58 Prognosis is Improving
25:08 Randomized Surgical Trials: Single Mets
26:20 RTOG-9508 Phase III Single Brain Metastasis Trial: Survival
27:03 RTOG 9508: Post-hoc Subset
27:40 RTOG 9508: Post-hoc GPA Re
28:18 Radiosurgery Trials
28:45 Brain Failure after SRS/S Alone
30:29 4 Brain Mets: Published Data
33:50 Baseline Characteristics 518 randomized patients
34:24 Primary Endpoint
35:06 Patient-Reported Outcomes
36:10 Impact of Tumor Biology
38:18 EGFR Mutated BM
41:55 Early Lessons: It is Actually the Addition of RT to iCls/Targeted Agents that Moves the Needle
42:55 Up-front SRS + ICls Improves LC and Reduces Brain Failure
43:40 ABC-X, Australian Asymptomatic Trial
The ABTA educational webinars are designed for brain tumor patients and caregivers to learn more about brain tumor types, treatments and research. Webinars are 60 minutes and free to all who are interested. To learn about upcoming webinars, visit bit.ly/3xev6HE.
For more information or additional resources, contact the American Brain Tumor Association at (800) 886-2282, info@abta.org or visit www.abta.org/.
3 окт 2024
